Vascular malformations and health-related quality of life a systematic review and meta-analysis

Henry L. Nguyen, George F. Bonadurer, Megha M. Tollefson

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

IMPORTANCE Patients with vascular malformations (VAMs) and vascular overgrowth syndromes have lower health-related quality of life (HRQoL) attributable to social stigmatization, poor mental health, severity, and pain. However, the factors that contribute to this decreased HRQoL are not clear. OBJECTIVE To perform a systematic review and meta-analysis of studies that used validated HRQoL instruments to compare the HRQoL of persons with VAMs with the US general population. DATA SOURCES A comprehensive search was performed in MEDLINE, Embase, PsycINFO, CINAHL, and Scopus from 1946 to March 31, 2017, with the consultation of an experienced librarian. STUDY SELECTION All VAMstudies with validated HRQoL instruments published in the English language were included. Case reports, review articles, non-English-language publications, and studies about the development of new HRQoL instruments were not included. DATA EXTRACTION AND SYNTHESIS Two reviewers assessed studies' eligibility and the risk of bias and performed data extraction. Themeta-analysis was performed using the random-effects model. Comparisons of means were performed using the unpaired, 2-sample t test. MAIN OUTCOMES AND MEASURES The outcomewas HRQoL. RESULTS Eleven studiesmet the inclusion criteria for a total of 692 patients with VAMs. Six studies (320 patients) were included in the meta-analysis, whereas 5 studies were included in the qualitative analysis (372 patients). Those with VAMs had lower 36-Item Short-Form Health Survey scores in bodily pain (mean difference, -11.87; 95%CI, -21.45 to -2.29; I2 = 92%; P = .02) and mental health (mean difference, -6.04; 95%CI, -11.55 to -0.52; I2 = 83%; P = .03) compared with the US general population. CONCLUSIONS AND RELEVANCE Patients with VAMs had increased pain and psychosocial distress compared with the US general population. Pain and psychological morbidity are associated with poorer HRQoL and may serve as indicators for quality of life.

Original languageEnglish (US)
Pages (from-to)661-669
Number of pages9
JournalJAMA Dermatology
Volume154
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Vascular Malformations
Meta-Analysis
Quality of Life
Pain
Mental Health
Language
Population
Librarians
Stereotyping
Health Surveys
MEDLINE
Blood Vessels
Publications
Referral and Consultation
Psychology
Morbidity

ASJC Scopus subject areas

  • Dermatology

Cite this

Vascular malformations and health-related quality of life a systematic review and meta-analysis. / Nguyen, Henry L.; Bonadurer, George F.; Tollefson, Megha M.

In: JAMA Dermatology, Vol. 154, No. 6, 01.06.2018, p. 661-669.

Research output: Contribution to journalReview article

@article{54314d1616304b72a54163bba0ced600,
title = "Vascular malformations and health-related quality of life a systematic review and meta-analysis",
abstract = "IMPORTANCE Patients with vascular malformations (VAMs) and vascular overgrowth syndromes have lower health-related quality of life (HRQoL) attributable to social stigmatization, poor mental health, severity, and pain. However, the factors that contribute to this decreased HRQoL are not clear. OBJECTIVE To perform a systematic review and meta-analysis of studies that used validated HRQoL instruments to compare the HRQoL of persons with VAMs with the US general population. DATA SOURCES A comprehensive search was performed in MEDLINE, Embase, PsycINFO, CINAHL, and Scopus from 1946 to March 31, 2017, with the consultation of an experienced librarian. STUDY SELECTION All VAMstudies with validated HRQoL instruments published in the English language were included. Case reports, review articles, non-English-language publications, and studies about the development of new HRQoL instruments were not included. DATA EXTRACTION AND SYNTHESIS Two reviewers assessed studies' eligibility and the risk of bias and performed data extraction. Themeta-analysis was performed using the random-effects model. Comparisons of means were performed using the unpaired, 2-sample t test. MAIN OUTCOMES AND MEASURES The outcomewas HRQoL. RESULTS Eleven studiesmet the inclusion criteria for a total of 692 patients with VAMs. Six studies (320 patients) were included in the meta-analysis, whereas 5 studies were included in the qualitative analysis (372 patients). Those with VAMs had lower 36-Item Short-Form Health Survey scores in bodily pain (mean difference, -11.87; 95{\%}CI, -21.45 to -2.29; I2 = 92{\%}; P = .02) and mental health (mean difference, -6.04; 95{\%}CI, -11.55 to -0.52; I2 = 83{\%}; P = .03) compared with the US general population. CONCLUSIONS AND RELEVANCE Patients with VAMs had increased pain and psychosocial distress compared with the US general population. Pain and psychological morbidity are associated with poorer HRQoL and may serve as indicators for quality of life.",
author = "Nguyen, {Henry L.} and Bonadurer, {George F.} and Tollefson, {Megha M.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1001/jamadermatol.2018.0002",
language = "English (US)",
volume = "154",
pages = "661--669",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Vascular malformations and health-related quality of life a systematic review and meta-analysis

AU - Nguyen, Henry L.

AU - Bonadurer, George F.

AU - Tollefson, Megha M.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - IMPORTANCE Patients with vascular malformations (VAMs) and vascular overgrowth syndromes have lower health-related quality of life (HRQoL) attributable to social stigmatization, poor mental health, severity, and pain. However, the factors that contribute to this decreased HRQoL are not clear. OBJECTIVE To perform a systematic review and meta-analysis of studies that used validated HRQoL instruments to compare the HRQoL of persons with VAMs with the US general population. DATA SOURCES A comprehensive search was performed in MEDLINE, Embase, PsycINFO, CINAHL, and Scopus from 1946 to March 31, 2017, with the consultation of an experienced librarian. STUDY SELECTION All VAMstudies with validated HRQoL instruments published in the English language were included. Case reports, review articles, non-English-language publications, and studies about the development of new HRQoL instruments were not included. DATA EXTRACTION AND SYNTHESIS Two reviewers assessed studies' eligibility and the risk of bias and performed data extraction. Themeta-analysis was performed using the random-effects model. Comparisons of means were performed using the unpaired, 2-sample t test. MAIN OUTCOMES AND MEASURES The outcomewas HRQoL. RESULTS Eleven studiesmet the inclusion criteria for a total of 692 patients with VAMs. Six studies (320 patients) were included in the meta-analysis, whereas 5 studies were included in the qualitative analysis (372 patients). Those with VAMs had lower 36-Item Short-Form Health Survey scores in bodily pain (mean difference, -11.87; 95%CI, -21.45 to -2.29; I2 = 92%; P = .02) and mental health (mean difference, -6.04; 95%CI, -11.55 to -0.52; I2 = 83%; P = .03) compared with the US general population. CONCLUSIONS AND RELEVANCE Patients with VAMs had increased pain and psychosocial distress compared with the US general population. Pain and psychological morbidity are associated with poorer HRQoL and may serve as indicators for quality of life.

AB - IMPORTANCE Patients with vascular malformations (VAMs) and vascular overgrowth syndromes have lower health-related quality of life (HRQoL) attributable to social stigmatization, poor mental health, severity, and pain. However, the factors that contribute to this decreased HRQoL are not clear. OBJECTIVE To perform a systematic review and meta-analysis of studies that used validated HRQoL instruments to compare the HRQoL of persons with VAMs with the US general population. DATA SOURCES A comprehensive search was performed in MEDLINE, Embase, PsycINFO, CINAHL, and Scopus from 1946 to March 31, 2017, with the consultation of an experienced librarian. STUDY SELECTION All VAMstudies with validated HRQoL instruments published in the English language were included. Case reports, review articles, non-English-language publications, and studies about the development of new HRQoL instruments were not included. DATA EXTRACTION AND SYNTHESIS Two reviewers assessed studies' eligibility and the risk of bias and performed data extraction. Themeta-analysis was performed using the random-effects model. Comparisons of means were performed using the unpaired, 2-sample t test. MAIN OUTCOMES AND MEASURES The outcomewas HRQoL. RESULTS Eleven studiesmet the inclusion criteria for a total of 692 patients with VAMs. Six studies (320 patients) were included in the meta-analysis, whereas 5 studies were included in the qualitative analysis (372 patients). Those with VAMs had lower 36-Item Short-Form Health Survey scores in bodily pain (mean difference, -11.87; 95%CI, -21.45 to -2.29; I2 = 92%; P = .02) and mental health (mean difference, -6.04; 95%CI, -11.55 to -0.52; I2 = 83%; P = .03) compared with the US general population. CONCLUSIONS AND RELEVANCE Patients with VAMs had increased pain and psychosocial distress compared with the US general population. Pain and psychological morbidity are associated with poorer HRQoL and may serve as indicators for quality of life.

UR - http://www.scopus.com/inward/record.url?scp=85048699573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048699573&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2018.0002

DO - 10.1001/jamadermatol.2018.0002

M3 - Review article

C2 - 29562060

AN - SCOPUS:85048699573

VL - 154

SP - 661

EP - 669

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 6

ER -